[1]
|
Virani, S.S., Alonso, A., Aparicio, H.J., et al. (2021) Heart Disease and Stroke Statistics-2021 Update: A Report from the American Heart Association. Circulation, 143, e254-e743. https://doi.org/10.1161/CIR.0000000000000950
|
[2]
|
Gologorsky, R.C. and Roy, S. (2020) Ultrafiltration for Management of Fluid Overload in Patients with Heart Failure. Artificial Organs, 44, 129-139. https://doi.org/10.1111/aor.13549
|
[3]
|
中国医疗保健国际交流促进会急诊医学分会, 中华医学会急诊医学分会, 中国医师协会急诊医师分会, 等. 急性心力衰竭中国急诊管理指南(2022) [J]. 临床急诊杂志, 2022, 23(8): 519-547.
|
[4]
|
中华医学会心血管病学分会心力衰竭学组中国医师协会, 心力衰竭专业委员会, 中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志, 2018, 46(10): 760-789.
|
[5]
|
Arrigo, M., Jessup, M., Mullens, W., et al. (2020) Acute Heart Failure. Nature Reviews. Disease Primers, 6, 16.
https://doi.org/10.1038/s41572-020-0151-7
|
[6]
|
沈祥礼, 李岚, 马骏, 等. 超滤治疗心力衰竭伴利尿剂抵抗患者的疗效和安全性: 一项单中心随机对照试验[J]. 中华心血管病杂志, 2021, 49(4): 340-347.
|
[7]
|
Boorsma, E.M., Ter Maaten, J.M., Damman, K., et al. (2020) Congestion in Heart Failure: A Contemporary Look at Physiology, Diagno-sis and Treatment. Nature Reviews. Cardiology, 17, 641-655.
https://doi.org/10.1038/s41569-020-0379-7
|
[8]
|
Rubio-Gracia, J., Demissei, B.G., Ter Maaten, J.M., et al. (2018) Prevalence, Predictors and Clinical Outcome of Residual Congestion in Acute Decompensated Heart Failure. Internation-al Journal of Cardiology, 258, 185-191.
https://doi.org/10.1016/j.ijcard.2018.01.067
|
[9]
|
Schaubroeck, H.A., Gevaert, S., Bagshaw, S.M., et al. (2020) Acute Cardiorenal Syndrome in Acute Heart Failure: Focus on Renal Replacement Therapy. European Heart Journal. Acute Cardiovascular Care, 9, 802-811.
https://doi.org/10.1177/2048872620936371
|
[10]
|
Costanzo, M.R. (2019) Ultrafiltration in Acute Heart Failure. Cardiac Failure Review, 5, 9-18.
https://doi.org/10.15420/cfr.2018.29.2
|
[11]
|
Yang, Y., Shen, C., Lu, J., et al. (2019) Early Continuous Ultrafiltra-tion in Chinese Patients with Congestive Heart Failure (EUC-CHF): Study Protocol for an Open-Label Registry-Based Prospective Clinical Trial. BMC Cardiovascular Disorders, 19, 249. https://doi.org/10.1186/s12872-019-1208-y
|
[12]
|
Silverstein, M.E., Ford, C.A., Lysaght, M.J., et al. (1974) Treat-ment of Severe Fluid Overload by Ultrafiltration. The New England Journal of Medicine, 291, 747-751. https://doi.org/10.1056/NEJM197410102911501
|
[13]
|
Costanzo, M.R., Ronco, C., Abraham, W.T., et al. (2017) Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further Research. Journal of the American College of Cardiology, 69, 2428-2445.
https://doi.org/10.1016/j.jacc.2017.03.528
|
[14]
|
Gao, L., Bian, Y., Cao, S., et al. (2021) Development and Valida-tion of a Simple-to-Use Nomogram for Predicting In-Hospital Mortality in Patients with Acute Heart Failure Undergoing Continuous Renal Replacement Therapy. Frontiers in Medicine, 8, Article ID: 678252. https://doi.org/10.3389/fmed.2021.678252
|
[15]
|
Davenport, A. and Honore, P.M. (2021) Continuous Renal Re-placement Therapy under Special Conditions Like Sepsis, Burn, Cardiac Failure, Neurotrauma, and Liver Failure. Semi-nars in Dialysis, 34, 457-471.
https://doi.org/10.1111/sdi.13002
|
[16]
|
Murugan, R., Ostermann, M., Peng, Z., et al. (2020) Net Ultrafiltration Pre-scription and Practice among Critically Ill Patients Receiving Renal Replacement Therapy: A Multinational Survey of Critical Care Practitioners. Critical Care Medicine, 48, e87-e97. https://doi.org/10.1097/CCM.0000000000004092
|
[17]
|
Truche, A.S., Darmon, M., Bailly, S., et al. (2016) Contin-uous Renal Replacement Therapy versus Intermittent Hemodialysis in Intensive Care Patients: Impact on Mortality and Renal Recovery. Intensive Care Medicine, 42, 1408-1417.
https://doi.org/10.1007/s00134-016-4404-6
|
[18]
|
Wobbe, B., Wagner, J., Szabó, D.K., et al. (2021) Ultrafiltration Is Better than Diuretic Therapy for Volume-Overloaded Acute Heart Failure Patients: A Meta-Analysis. Heart Failure Re-views, 26, 577-585.
https://doi.org/10.1007/s10741-020-10057-7
|
[19]
|
Karkar, A. (2019) Continuous Renal Replacement Therapy: Principles, Modalities, and Prescription. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 30, 1201-1209. https://doi.org/10.4103/1319-2442.275463
|
[20]
|
Chen, H.Y., Chou, K.J., Fang, H.C., et al. (2015) Effect of Ultra-filtration versus Intravenous Furosemide for Decompensated Heart Failure in Cardiorenal Syndrome: A Systematic Re-view with Meta-Analysis of Randomized Controlled Trials. Nephron, 129, 189-196. https://doi.org/10.1159/000371447
|
[21]
|
Tandukar, S. and Palevsky, P.M. (2019) Continuous Renal Replacement Therapy: Who, When, Why, and How. Chest, 155, 626-638. https://doi.org/10.1016/j.chest.2018.09.004
|
[22]
|
Barrios-Araya, S., Espinoza-Coya, M.E., Ñuñez-Gómez, K., et al. (2019) Experience with Inline Intermittent Hemodiafiltration as Renal Replacement Therapy in Critically Ill Patients. Re-vista Medica de Chile, 147, 409-415.
https://doi.org/10.4067/S0034-98872019000400409
|
[23]
|
Ponikowski, P., Voors, A.A., Anker, S.D., et al. (2016) 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure: The Task Force for the Di-agnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC). Developed with the Special Contribution of the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure, 18, 891-975. https://doi.org/10.1002/ejhf.592
|
[24]
|
Verbrugge, F.H. (2018) Editor’s Choice-Diuretic Resistance in Acute Heart Failure. European Heart Journal. Acute Cardiovascular Care, 7, 379-389. https://doi.org/10.1177/2048872618768488
|
[25]
|
van Diepen, S., Tymchak, W., Bohula, E.A., et al. (2020) Inci-dence, Underlying Conditions, and Outcomes of Patients Receiving Acute Renal Replacement Therapies in Tertiary Car-diac Intensive Care Units: An Analysis from the Critical Care Cardiology Trials Network Registry. American Heart Journal, 222, 8-14.
https://doi.org/10.1016/j.ahj.2020.01.005
|
[26]
|
Rewa, O.G., Villeneuve, P.M., Lachance, P., et al. (2017) Quality Indicators of Continuous Renal Replacement Therapy (CRRT) Care in Critically Ill Patients: A Systematic Review. Inten-sive Care Medicine, 43, 750-763.
https://doi.org/10.1007/s00134-016-4579-x
|
[27]
|
Bagshaw, S.M., Wald, R., Adhikari, N., et al. (2020) Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury. The New England Journal of Medicine, 383, 240-251. https://doi.org/10.1056/NEJMoa2000741
|
[28]
|
Murugan, R., Bellomo, R., Palevsky, P.M., et al. (2021) Ultrafiltra-tion in Critically Ill Patients Treated with Kidney Replacement Therapy. Nature Reviews. Nephrology, 17, 262-276. https://doi.org/10.1038/s41581-020-00358-3
|
[29]
|
Liu, C., Mao, Z., Kang, H., et al. (2016) Regional Citrate versus Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Patients: A Meta-Analysis with Trial Sequential Analysis of Randomized Controlled Trials. Critical Care (London, England), 20, 144. https://doi.org/10.1186/s13054-016-1299-0
|
[30]
|
Heidenreich, P.A., Bozkurt, B., Aguilar, D., et al. (2022) 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiolo-gy/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology, 79, e263-e421.
https://doi.org/10.1161/CIR.0000000000001063
|
[31]
|
胡杨, 杨涵, 黄杏. 连续性静脉-静脉血液滤过治疗急性心肌梗死后利尿剂抵抗心力衰竭的临床研究[J]. 中西医结合心脑血管病杂志, 2022, 20(17): 3186-3189.
|
[32]
|
Marenzi, G., Muratori, M., Cosentino, E.R., et al. (2014) Continuous Ultrafiltration for Congestive Heart Failure: The CUORE Trial. Journal of Cardiac Failure, 20, 371-378. https://doi.org/10.1016/j.cardfail.2013.11.004
|
[33]
|
Costanzo, M.R., Negoianu, D., Fonarow, G.C., et al. (2015) Rationale and Design of the Aquapheresis versus Intravenous Diuretics and Hospitalization for Heart Failure (AVOID-HF) Trial. American Heart Journal, 170, 471-482.
https://doi.org/10.1016/j.ahj.2015.05.019
|